MidMarketNow
Get the Weekly

SweGaN raises EUR 12.1m to scale GaN epiwafers

#SweGaN#GaN-on-SiC#epitaxial wafers#Thisbe AB#North Ventures
By SofiaAI-generated3 min read

Deal at a glance

Type
funding · Series B
Enterprise value
€12.1M
Original amount
EUR 12.1M
Target
SweGaN
Acquirer
Investor
Thisbe AB, North Ventures
Sector
Technology
Region
Announced

Deal-ID: MMN-000875

Key facts

Buyer
Thisbe AB, North Ventures
Target
SweGaN
Sector
Technology
Geography
Deal volume
€12.1M
Date

European chip resilience is increasingly being built upstream, where device makers buy the materials that determine yield, performance and lead times. SweGaN, a Sweden-based producer of gallium nitride on silicon carbide (GaN-on-SiC) epitaxial wafers, has raised EUR 12.1 million in a recently announced Series B round led by Thisbe AB and North Ventures, alongside existing shareholders.

The company said the proceeds will be used to expand production capacity to meet increasing customer demand and to support development of next-generation GaN-on-SiC materials for high-performance semiconductor applications. SweGaN manufactures and is headquartered in Linköping, Sweden, giving the round a clear European production footprint.

Why investors are leaning into the materials layer

Unlike many semiconductor financings focused on fabless design or end-device assembly, SweGaN sits in the materials and epitaxy layer. The company positions epiwafers as the starting point for high-performance chips and, by extension, a key lever for supply-chain resilience. That framing is aligned with policy tailwinds: SweGaN has publicly tied its messaging to EU Chips Act 2.0 and the broader push to secure stable supply for critical sectors.

Commercial traction is also part of the story. A separate April 2026 report cited SweGaN having already won commercial orders worth SEK 25 million, suggesting active customer demand and near-term revenue contribution. For an upstream supplier, that matters because qualification cycles can be long, and repeat orders typically indicate that customers are moving from evaluation into production ramps.

What the EUR 12.1m is likely funding, in operational terms

SweGaN stated that the Series B will expand production capacity and strengthen its commercial presence in key global markets while accelerating R&D. In practice, scaling an epitaxy business tends to concentrate spend in three areas:

  • Capacity and throughput: adding or upgrading epitaxy tools, improving process stability and increasing usable output per run.
  • Quality and consistency: tighter process control to meet device makers’ specifications, which can translate into higher switching costs once a wafer spec is qualified.
  • Commercial coverage: deeper field application support in target markets, which is often necessary to win sockets with power electronics and RF customers.

The company described the round as an up-round, led by Thisbe AB and North Ventures with participation from existing shareholders, signalling continued investor confidence. SweGaN also said total funding reached USD 41 million after the round, consistent with a multi-step growth financing path rather than a one-off capital injection.

Competitive context: upstream leverage, but qualification friction

GaN-on-SiC materials are used in demanding applications where performance and reliability are non-negotiable. That can create pricing power for suppliers that consistently hit customer specs, but it also raises the bar: customers typically qualify materials carefully, and any slip in uniformity or defectivity can slow adoption.

If SweGaN converts its stated demand signals into sustained capacity utilisation, it strengthens its position as a European upstream alternative in a part of the value chain often dominated by non-European supply. The strategic implication is less about chasing broad semiconductor volume and more about becoming a preferred, qualified source for high-performance segments where lead times and security of supply carry real economic value.

Outlook

This financing fits a with-trend pattern: capital moving into European semiconductor infrastructure beyond chip design, with a focus on supply-chain resilience and manufacturing depth. The near-term execution test is straightforward: can SweGaN scale output without compromising the characteristics that customers qualified in the first place.

What this enables

  • Higher GaN-on-SiC epiwafer output to match stated customer demand
  • Faster iteration on next-generation GaN-on-SiC material stacks
  • Stronger commercial presence in key global markets, supported by application-facing resources

What to watch

  • Evidence of repeat orders and expanded customer qualifications beyond the SEK 25m reported order base
  • Ramp metrics: lead times, yields and consistency as capacity expands
  • How closely the company’s EU Chips Act 2.0 positioning translates into partnerships or programme support
  • Whether the up-round momentum continues into follow-on industrial collaborations or longer-term supply agreements

Companies & investors in this story

More in this sector

We use privacy-respecting product analytics to understand how readers use MidMarketNow and improve it. No personal data (email, IP) is sent. See our privacy policy.